Tumor homology with self as a biomarker for response to checkpoint inhibitor therapy by Corey Iacono | Nov 17, 2022EpiVaxTx_SITC22_Melanoma_28Oct22_56Wx31.5H
A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform by Riley Nolan | Jun 7, 2022A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
